(Image source from: Canva.com)
Infertility is frequently seen as a problem that only affects women in India, even though research shows that male-related issues are responsible for nearly half of all infertility situations. Recently, a new large study published in the Indian Journal of Medical Research (IJMR) has brought attention to another important fact: the heavy financial strain of treating male infertility. The researchers discovered that couples seeking male infertility treatment spent nearly as much money out of their own pockets as those suffering from endometriosis, a long-term and often painful gynecological issue often linked to female infertility that is well-known for its treatment expenses. These results challenge the belief that costs related to infertility mainly come from female health issues and highlight the need for more extensive health insurance and public health initiatives. The research, carried out in both public and private top healthcare centers in India, also found that almost six out of ten couples dealt with huge health expenditures because of infertility treatment.
With about one in six adults around the world facing infertility and many treatments primarily funded through personal savings in India, experts say these results reveal a major but often overlooked public health issue. According to the World Health Organization (WHO), infertility is defined as the failure to conceive after trying for 12 months or more with regular unprotected sex. WHO estimates show that about 17.5% of adults globally will experience infertility at some point in their lives, making it a significant health problem worldwide. However, in India, most infertility services are not included in major public health programs. Getting a diagnosis and treatment usually requires multiple visits, lab tests, imaging, medications, and assisted reproductive technologies, all of which are typically paid for by patients themselves. The new IJMR research aimed to determine these expenses by analyzing costs among 500 couples being treated for five common causes of infertility: polycystic ovary syndrome (PCOS), endometriosis, tubal-factor infertility, uterine-factor infertility, and male infertility.
One of the most surprising results from the study was that the financial strain of male infertility treatment was almost the same as that of endometriosis, which has generally been seen as one of the most expensive infertility-related conditions. The researchers found:
Median yearly out-of-pocket costs for endometriosis: Rs 16,943
Median yearly out-of-pocket costs for male infertility: Rs 16,566
Median yearly costs for all infertility issues: Rs 11,317.
The small difference in costs between male infertility and endometriosis treatments implies that problems with male reproductive health impose a much heavier financial load on families than is typically understood. The study also indicated that male infertility represented nearly one-fifth of all infertility diagnoses among the couples involved. Investigations for male infertility often require specific tests, hormonal assessments, semen evaluations, genetic tests, and sometimes surgical procedures. Treatment options may include medications, hormone therapies, sperm retrieval methods, or assisted reproductive techniques like intrauterine insemination (IUI) and intracytoplasmic sperm injection (ICSI). The researchers pointed out that direct medical expenses were the biggest part of the costs related to infertility. These included doctor consultations, diagnostic tests, medications, and procedures. Many couples also faced additional costs like travel, accommodation, and lost wages due to frequent hospital visits.
The research showed marked differences in spending between public and private healthcare services. The average yearly out-of-pocket costs were:
Rs 14,217 in private clinics
Rs 8,355 in public hospitals.
Private healthcare's direct medical costs were almost four times higher than those at government hospitals. However, patients using public services often encountered greater travel and indirect expenses since many specialized fertility treatments are mainly located in urban top-tier medical centers. On average, couples traveled 57 kilometers for treatment, with some reporting trips over 1,000 kilometers. One of the most alarming discoveries was the level of financial strain faced by families. The researchers characterized catastrophic health expenditure as spending related to infertility that exceeded 40% of a household's annual spending on non-food items. Overall, 59.4% of couples experienced such catastrophic health expenditure while pursuing infertility treatment. The risk was particularly high among:
Lower-income families
Couples receiving IUI treatment
Patients with other health issues
Families dealing with endometriosis or uterine-related infertility.
Only 1% of those surveyed stated they had insurance for infertility-related costs, while many had to depend on loans, savings, or borrowing to pay for treatment.
The study is timely, as infertility is becoming more recognized as a public health issue instead of just a personal one. The WHO has highlighted repeatedly that infertility affects millions of people worldwide and can lead to serious emotional, psychological, and social repercussions. Beyond medical hurdles, the costs of treatment can drive families into debt, create delays in receiving care, or force couples to stop treatment completely. Researchers suggest that infertility treatment should be incorporated into general health funding systems and insurance plans to alleviate financial pressures and ensure fair access to care. The results are especially important since they question traditional views related to infertility. By showing that male infertility can carry similar financial burdens as some costly female reproductive issues, the study calls for a more balanced and inclusive stance on reproductive healthcare.
The recent IJMR study illuminates a frequently overlooked aspect of infertility treatment in India: the cost of treating male infertility can be nearly as high as that of endometriosis. At the same time, the research indicates that infertility treatments are mainly funded through personal spending, which puts many couples at financial risk. With almost sixty percent of families facing catastrophic health expenditure and the lack of insurance coverage, experts believe these results should encourage policymakers to think about increasing public funding, enhancing insurance benefits, and acknowledging infertility as a critical part of reproductive health.
